Persistent loneliness in midlife is an independent risk factor for later dementia and Alzheimer disease.
With cannabis in the United States becoming more widely available for medical and recreational use, some with Parkinson disease (PD) are trying cannabis to control symptoms. However, not that much is currently known about the attitudes and experiences regarding cannabis use among those with PD.
The sNDA submission was supported by data from the pivotal phase 3 HARMONY study.
Study researchers sought to assess the racial differences in triggering receptor expressed on myeloid cells 2 in patients with Alzheimer disease.
With no conclusive preclinical diagnostic test for Parkinson disease, diagnosis is achieved primarily through observations by a physician of the decline in motor functions. And while studies of sebum are commonplace in dermatological conditions, sebum as a biofluid has rarely been used in disease diagnostics.
Increased levels of physical activity may have a protective effect on apolipoprotein E ε4-related cognitive decline in early PD.
The researchers sought to estimate the age-specific incidence and prevalence of dementia diagnoses among older adults with schizophrenia in the United States compared to those without serious mental illness.
Investigators sought to examine the safety, pharmacokinetics, and pharmacodynamics of risdiplam in infants with type 1 spinal muscular atrophy.
For people with dementia with symptoms of depression, without a MDD, nondrug interventions are more efficacious than drug interventions.
Donanemab, which targets a modified form of deposited amyloid-ß, results in slightly less cognitive and functional decline than placebo.